BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 25091804)

  • 1. The challenge of identification of autoantibodies specific to systemic autoimmune rheumatic diseases in high throughput operation: proposal of reliable and feasible strategies.
    Pereira KM; Dellavance A; Andrade LE
    Clin Chim Acta; 2014 Nov; 437():203-10. PubMed ID: 25091804
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Application of linear discriminant analysis in performance evaluation of extractable nuclear antigen immunoassay systems in the screening and diagnosis of systemic autoimmune rheumatic diseases.
    Pi D; de Badyn MH; Nimmo M; White R; Pal J; Wong P; Phoon C; O'Connor D; Pi S; Shojania K
    Am J Clin Pathol; 2012 Oct; 138(4):596-603. PubMed ID: 23010715
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Detection of autoantibodies to nuclear antigens by EIA and IF techniques.
    Alem M; Moghadam S; Malki J; Zaidi A; Nayak N; Li TM
    Allerg Immunol (Paris); 1997 Sep; 29(7):188, 191-4. PubMed ID: 9373708
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Detection of anti-ENA and anti-dsDNA antibodies using line immunoassay in systemic autoimmune diseases].
    Kim JM; Ihm CH; Sin DH; Ihm MK; Sim SC
    Korean J Lab Med; 2008 Oct; 28(5):353-61. PubMed ID: 18971616
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of three commercially available enzyme immunoassays for the screening of autoantibodies to extractable nuclear antigens.
    Jaskowski TD; Schroder C; Martins TB; Mouritsen L; Hill HR
    J Clin Lab Anal; 1995; 9(3):166-72. PubMed ID: 7602423
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Italian multicentre study for application of a diagnostic algorithm in autoantibody testing for autoimmune rheumatic disease: conclusive results.
    Bonaguri C; Melegari A; Ballabio A; Parmeggiani M; Russo A; Battistelli L; Aloe R; Trenti T; Lippi G
    Autoimmun Rev; 2011 Nov; 11(1):1-5. PubMed ID: 21741498
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anti-DFS70/LEDGF antibodies are more prevalent in healthy individuals compared to patients with systemic autoimmune rheumatic diseases.
    Mahler M; Parker T; Peebles CL; Andrade LE; Swart A; Carbone Y; Ferguson DJ; Villalta D; Bizzaro N; Hanly JG; Fritzler MJ
    J Rheumatol; 2012 Nov; 39(11):2104-10. PubMed ID: 22942262
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of the analytical and clinical performances of two different routine testing protocols for antinuclear antibody screening.
    González Rodríguez C; Fuentes Cantero S; Pérez Pérez A; Vázquez Barbero FJ; León Justel A
    J Clin Lab Anal; 2021 Sep; 35(9):e23914. PubMed ID: 34347308
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A critical evaluation of enzyme immunoassay kits for detection of antinuclear autoantibodies of defined specificities. II. Potential for quantitation of antibody content.
    Tan EM; Smolen JS; McDougal JS; Fritzler MJ; Gordon T; Hardin JA; Kalden JR; Lahita RG; Maini RN; Reeves WH; Rothfield NF; Takasaki Y; Wiik A; Wilson M; Koziol JA
    J Rheumatol; 2002 Jan; 29(1):68-74. PubMed ID: 11824974
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Detection of antinuclear antibodies: comparative evaluation of enzyme immunoassay and indirect immunofluorescence methods.
    Homburger HA; Cahen YD; Griffiths J; Jacob GL
    Arch Pathol Lab Med; 1998 Nov; 122(11):993-9. PubMed ID: 9822128
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical value of anti-DFS70 antibodies in a cohort of patients undergoing routine antinuclear antibodies testing.
    Yumuk Z; Demir M
    J Immunol Methods; 2020 May; 480():112754. PubMed ID: 32057435
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A critical evaluation of enzyme immunoassays for detection of antinuclear autoantibodies of defined specificities. I. Precision, sensitivity, and specificity.
    Tan EM; Smolen JS; McDougal JS; Butcher BT; Conn D; Dawkins R; Fritzler MJ; Gordon T; Hardin JA; Kalden JR; Lahita RG; Maini RN; Rothfield NF; Smeenk R; Takasaki Y; van Venrooij WJ; Wiik A; Wilson M; Koziol JA
    Arthritis Rheum; 1999 Mar; 42(3):455-64. PubMed ID: 10088768
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Selective detection of autoimmune antibodies to single- and double-stranded DNA by enzyme immunoassay.
    Makowski GS; Ramsby ML
    Ann Clin Lab Sci; 2003; 33(2):142-8. PubMed ID: 12817617
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An italian multicenter study for application of a diagnostic algorithm in autoantibody testing.
    Bonaguri C; Melegari A; Dall'Aglio P; Ballabio A; Terenziani P; Russo A; Battistelli L; Aloe R; Camisa R; Campaniello G; Sartori E; Monica C
    Ann N Y Acad Sci; 2009 Sep; 1173():124-9. PubMed ID: 19758140
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Detection of autoantibodies to extractable nuclear antigens in autoimmune diseases of rheumatic origin using immunoblotting--comparison with counter-electrophoresis].
    Hiepe F; Kiessig ST; Yamamoto K; Prokop G; Mielke F; Lukowsky A; Schlaak B; Miyamoto T; Apostoloff E
    Z Rheumatol; 1990; 49(5):304-9. PubMed ID: 2080688
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical performance evaluation of a novel rapid response chemiluminescent immunoassay for the detection of autoantibodies to extractable nuclear antigens.
    Bentow C; Swart A; Wu J; Seaman A; Manfredi M; Infantino M; Benucci M; Lakos G; Mahler M
    Clin Chim Acta; 2013 Sep; 424():141-7. PubMed ID: 23727029
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HEp2 ANA EIA: a new fully automated assay for the screening of antinuclear antibodies.
    Lehmann HP; Fühling I; Ott C; Hüdepohl B; Haass M
    Isr Med Assoc J; 2000 Aug; 2(8):646-8. PubMed ID: 10979370
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Laboratory screening of connective tissue diseases by a new automated ENA screening assay (EliA Symphony) in clinically defined patients.
    González C; García-Berrocal B; Pérez M; Navajo JA; Herraez O; González-Buitrago JM
    Clin Chim Acta; 2005 Sep; 359(1-2):109-14. PubMed ID: 15894301
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High concomitance of disease marker autoantibodies in anti-DFS70/LEDGF autoantibody-positive patients with autoimmune rheumatic disease.
    Muro Y; Sugiura K; Morita Y; Tomita Y
    Lupus; 2008 Mar; 17(3):171-6. PubMed ID: 18372356
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Detection of anti-ENA autoantibodies in patients with systemic connective tissue diseases. Analytical variability and diagnostic sensitivity of 4 methods].
    Villalta D; Bizzaro N; Tonutti E; Visentin D; Manoni F; Piazza A; Toffolo L; Rizzotti P; Clemen P; Pradella M; Bassetti D; Tozzoli R
    Recenti Prog Med; 1999 Nov; 90(11):579-84. PubMed ID: 10608146
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.